Abstract
The in vitro synergistic activity of aztreonam in combination with piperacillin, moxalactam, cefotaxime, cefoperazone, and amikacin was examined against multiply resistant isolates of the family Enterobacteriaceae and Pseudomonas aeruginosa. Aztreonam in combination with amikacin demonstrated synergy against 71% of the isolates, whereas combinations of aztreonam plus a second beta-lactam demonstrated synergy against 42% of the isolates.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 283-285 |
| Number of pages | 3 |
| Journal | Antimicrobial agents and chemotherapy |
| Volume | 25 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 1 1984 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
Fingerprint Dive into the research topics of 'In vitro activity of aztreonam in combination with newer β-lactams and amikacin against multiply resistant gram-negative bacilli'. Together they form a unique fingerprint.
Cite this
Buesing, M. A., & Jorgensen, J. H. (1984). In vitro activity of aztreonam in combination with newer β-lactams and amikacin against multiply resistant gram-negative bacilli. Antimicrobial agents and chemotherapy, 25(2), 283-285. https://doi.org/10.1128/AAC.25.2.283